New cancer clinical trial: EGFR-IL12-CART Cells for Patients With Metastatic Colorectal Cancer

Published on: May 31, 2018 at 12:00PM
Condition:   Metastatic Colorectal Cancer
Intervention:   Biological: EGFR IL12 CART
Sponsors:   Shenzhen Second People's Hospital;   The Pregene (ShenZhen) Biotechnology Company, Ltd.
Not yet recruiting
https://ift.tt/2kDZdpd